Purpose We investigated the influence of inorganic nitrate ( NO − 3 ) supplementation on local sweating and cutaneous vascular responses during exercise in hot conditions. Method Eight healthy, young subjects were assigned in a randomized, double-blind, crossover design to receive NO , 87 ± 28 and 336 ± 156 nM) concentrations were higher after BR compared to PL supplementation (P ≤ 0.011, n = 6). Oesophageal, mean skin, and mean body temperatures during exercise were not different between conditions. In addition, BR supplementation did not affect SR, SkBF, and CVC during exercise. A lower MAP was found after 30 min of exercise following BR supplementation (112 ± 6 and 103 ± 6 mmHg for PL and BR, respectively, P = 0.021). Conclusion These results suggest that inorganic NO − 3 supplementation, which increases the potential for O 2 -independent NO production, does not affect local sweating and cutaneous vascular responses, but attenuates blood pressure in young healthy subjects exercising in a hot environment.
Introduction
Sweating and cutaneous vasodilation are vital physiological functions that dissipate heat from the body during exercise. Previous studies suggest that nitric oxide (NO) is an important signalling molecule for modulating sweat rate (SR) and cutaneous blood flow in humans Welch et al. 2009; Kellogg et al. 1998; McNamara et al. 2014; Wilkins et al. 2003; Fujii et al. 2016 ). There are two pathways for NO generation in humans. The most recognized is the enzymatic NO synthase (NOS) pathway, which catalyses the oxidation of l-arginine to NO and L -citrulline (Moncada and Higgs 1991) . More recently, it has been shown that NO can be produced O 2 -independently through the stepwise reduction of inorganic nitrate ( NO → NO pathway) . The importance of NOSderived NO on physiological responses that promote heat loss is already well defined, as evidenced by a lower SR and cutaneous vasodilation during exercise or passive heat stress following inhibition of skin NOS activity (Welch et al. 2009; Kellogg et al. 1998; Wilkins et al. 2003; Stapleton et al. 2014; Fujii et al. 2016; Amano et al. 2017a ). On the other hand, the influence of the NO − 3 → NO − 2 → NO pathway on heat loss responses during exercise has not been fully investigated.
Following ingestion NO − 3 is absorbed and concentrated by the salivary glands for delivery to the oral cavity for second pass metabolism (Spiegelhalder et al. 1976) . Here, oral microflora catalyses the reduction of NO − 3 to NO − 2 (Duncan et al. 1995) . Ingested NO − 2 is subsequently reduced to NO and other reactive nitrogen species in the acidic pH of the stomach (Benjamin et al. 1994) . It is also clear that a portion of the ingested NO − 2 passes into the systemic circulation, as evidenced by a dose-dependent increase in venous plasma ] after oral NO − 3 ingestion (Kapil et al. 2010; Wylie et al. 2013a) . As this circulating NO − 2 arrives at the skin microvasculature, the ensuing fall in PO 2 (Kerger et al. 1995) would be conducive to the reduction of NO − 2 to NO (Castello et al. 2006 ) and might promote increases in NOmediated cutaneous vasodilation (Kellogg et al. 1998; Fujii et al. 2016; Wilkins et al. 2003; Shastry et al. 1998; McNamara et al. 2014) . It is also possible for circulating NO − 2 to pass into the eccrine sweat glands (Weller et al. 1996) . Subsequently, NO − 2 might be reduced to NO, a reaction that would be facilitated by the acidic pH present in eccrine sweat (Morimoto and Johnson 1967) . In addition, NO − 3 secreted in sweat might undergo reduction to NO − 2 when exposed to dermal NO − 3 reductases with this NO − 2 undergoing subsequent reduction to NO within the acidic conditions of the skin (Burry et al. 2001; Weller et al. 1996) . This dermal NO then has the potential to diffuse through the skin to promote vasodilation (Vercelino et al. 2013) . Therefore, NO − 3 supplementation has the potential to augment sweating and cutaneous vascular responses via NO-mediated signalling during exercise.
In contrast to the postulate that NO − 3 supplementation has the potential to augment SR, it has recently been reported that dietary NO − 3 supplementation does not affect whole body sweat loss (indirectly inferred from changes in body mass) during submaximal treadmill walking in hot conditions (Kuennen et al. 2015) . However, it is important to note the large inter-regional differences in local SR and skin blood flow (SkBF) previously reported across human skin (Havenith et al. 2008; Smith and Havenith 2011; Taylor and Machado-Moreira 2013; Kuno 1956; Hertzman and Randall 1948) . Since higher SkBF would deliver more NO − 2 to the sweat gland, NO − 3 supplementation might be particularly effective at augmenting local SR at skin sites where blood flow is high (e.g., torso) compared to skin sites where blood flow is low (e.g., extremes) (Hertzman and Randall 1948) . It has been reported that NO − 3 supplementation can increase cutaneous vasodilation to local heating and whole body passive heat stress (Levitt et al. 2015) . However, since disparate mechanisms underlie cutaneous blood flow regulation at rest and during exercise (McNamara et al. 2014; Fujii et al. 2016) and since the influence of NO − 3 supplementation on regional SkBF has not been investigated, further research is required to explore whether the greater cutaneous blood flow after NO − 3 supplementation is also manifest during exercise, and whether these effects might be site-specific.
The purpose of the present study was to investigate the influence of NO − 3 -rich beetroot juice (BR) supplementation on local sweating and cutaneous vascular responses during exercise in a hot environment. We hypothesized that BR supplementation would augment local sweating and cutaneous vasodilation on the chest to a greater extent than on the forearm during exercise in a hot condition.
Materials and methods

Ethical approval
Each participant was informed of the purpose and procedures of the study prior to providing written informed consent. This study was approved by the Human Subjects Committee of the Graduate School of Human Development and Environment, Kobe University (Kobe, Japan), and conformed to the standards set forth in the latest revision of the Declaration of Helsinki.
Participants
Five males and three females participated in the present study (mean ± SD age: 24 ± 4 years, height: 1.70 ± 0.09 m, and mass: 62.7 ± 10.3 kg, maximum oxygen uptake, V O 2max : 43 ± 6 ml/kg/min). Participants were healthy and active and were excluded if they had history of hypertension, heart disease, diabetes, autonomic disorders or smoking. All participants were not currently taking prescription medication. None of the females were using oral contraceptives and all participated in the experimental testing sessions either during the self-reported follicular or luteal phases without crossing phases. All experiments were conducted between the month of June and August.
Dietary intervention
Participants were randomly assigned in a crossover, doubleblind design to receive 3 days of dietary supplementation with NO concentration and peak reduction in systolic blood pressure following the ingestion of 8 mmol NO − 3 (Breese et al. 2017; Cermak et al. 2012; Lansley et al. 2011; Kuennen et al. 2015) . The NO − 3 -depleted BR placebo beverage was identical in color, taste, smell and texture to the experimental NO − 3 -rich BR beverage. The PL beverage was created by passage of the juice, before pasteurization, through a column containing Purolite A520E ion exchange resin, which selectively removes NO − 3 ions. Four participants began with the BR condition, and the other four participants began with the PL condition. The subjects were instructed to consume the beverages (70 mL in the morning and afternoon) on days 1-2 of the supplementation period. On day 3, the subjects were instructed to consume the beverages over a 10-min period, 2 h prior to the start of the exercise test (see below), based on recent evidence that plasma [ NO (Wylie et al. 2013b) . A 7-day washout period separated each supplementation period. Throughout the study, participants were asked to refrain from consumption of green leafy vegetables (e.g., Spinach), processed meats (e.g., Bacon), and Japanese traditional foods (e.g., Seaweed, Sayaingen beans, Chin gin cai) which are high in NO − 3 (Sobko et al. 2010) . Since the oral bacteria are integrated for reducing NO (Govoni et al. 2008) , participants were also asked to refrain the use of mouthwash.
Exercise protocol
After arrival at the laboratory on experimental days, venous blood samples were drawn from an antecubital vein in a seated position in an air-conditioned room (∼ 27 °C) from 6 of 8 subjects who consented to venipuncture. All exercise trials were performed in an environmental chamber (SR-3000; Nagano Science, Osaka, Japan) maintained at an ambient temperature of 30 °C and relative humidity of 50% with minimal air movement. Upon entering the chamber, participants rested in the semi-supine position for a minimum of 60 min while instruments were attached. After recording the baseline data for 5 min, participants started cycling at an exercise intensity of 55% of maximum oxygen uptake ( V O 2max ) for 30 min.
Measurements
Oesophageal temperature (T es ) was measured continuously using a thermocouple temperature probe (Inui Engineering, Higashi Osaka, Japan). The tip of the probe was covered by silicon and inserted at a distance of one-fourth of the participant's standing height from the external nares past the nostril and into the esophagus. Skin temperatures were measured at six skin sites using the same thermocouples attached with surgical tape. Mean skin temperature (T sk ) was calculated using six skin temperatures weighted to the regional proportions determined as follows: forehead 7%, abdomen 35%, forearm 14%, hand 5%, lower leg 13%, and foot 7% (Mitchell and Wyndham 1969) . The mean body temperature (T b ) was calculated as 0.8 × T es + 0.2 × T sk (Stolwijk and Hardy 1966) .
Local SR was measured continuously on left ventral forearm (centre of the forearm) and chest (under the left clavicle) using a ventilated plastic capsule (3.14 cm 2 ) that was attached to the skin using collodion. Anhydrous nitrogen gas was passed through each capsule over the skin surface at a rate of 0.7 Lmin − 1 . Water content from the effluent air was measured using a capacitance hygrometer (HMP50; Vaisala, Helsinki, Finland). An index of local SkBF on the forearm and chest were measured continuously using laser Doppler velocimetry (ALF21; Advance, Tokyo, Japan) located adjacent to the ventilated capsule. Cutaneous vascular conductance (CVC) was calculated from the ratio of SkBF to mean arterial blood pressure (MAP). All temperature, SR and SkBF data were recorded at 1-s intervals using a data logger (MX100; Yokogawa, Tokyo, Japan) and simultaneously displayed (MX100 standard software; Yokogawa, Tokyo, Japan) and recorded. Heart rate (HR) and MAP were continuously measured from left middle finger using the Finometer system (Finometer; Finapres Medical Systems, Amsterdam, The Netherlands). Standardized calibration was conducted before each trial. Ratings of perceived exertion (RPE) was measured every 5 min based on Borg 6-20 scale (Borg 1970) .
Venous blood samples (~ 4 ml) were drawn into lithiumheparin tubes (7.5 ml Monovette Lithium Heparin, Sarstedt, Leicester, UK), which have very low levels of NO − 2 and NO − 3 . Within 3 min of collection, the samples were centrifuged at 2700 g and 4 °C for 10 min. Plasma was extracted and immediately frozen at − 80 °C for later analysis of NO − 2 and NO − 3 using a modification of the chemiluminescence technique (Bateman et al. 2002) . All glassware, utensils, and surfaces were rinsed with deionized water to remove residual NO of the undiluted (non-deproteinized) plasma was determined by its reduction to NO in the presence of glacial acetic acid and 4% (w/v) aqueous NaI. The spectral emission of electronically excited nitrogen dioxide, produced from the reaction of NO with ozone, was detected by a thermoelectrically cooled, red-sensitive photomultiplier tube housed in a Sievers gas-phase chemiluminescence nitric oxide analyzer (Sievers NOA 280i. Analytix Ltd, Durham, UK). The NO − 2 concentration was determined by plotting signal (mV) area against a calibration plot of 100 nM to 1 µM sodium nitrite. Before determination of NO − 3 , samples were deproteinized using zinc sulfate (ZnSO 4 )/sodium hydroxide (NaOH) precipitation. Aqueous ZnSO 4 [300 µl 5% (w/v)] and 500 µl 0.18 M NaOH were added to 100 µl of sample and vortexed for 30 s before being left to stand at room temperature for 15 min. Thereafter, samples were centrifuged at 4,000 rpm for 5 min, and the supernatant was removed for subsequent analysis. The NO − 3 concentration of the deproteinized plasma sample was determined by its reduction to NO in the presence of 0.8% (w/v) vanadium trichloride in 1 M HCl. The production of NO was detected using the chemiluminescence nitric oxide analyzer, as described above.
Data and statistical analyses
Variables were averaged for 5 min at pre-exercise baseline and for every 1 min during exercise. SR and CVC were plotted against the changes in T es (ΔT es ) and T b (ΔT b ) during exercise to assess the core temperature threshold and slope for inducing the responses. Segmented regression analysis was used to determine the core temperature onset thresholds and slopes of local SR and cutaneous vasodilation at each skin site (Cheuvront et al. 2009 ). The slopes were defined based on the linear portion of the changes in SR and CVC before and after the appearance of the onset thresholds during the exercise.
Baseline data in the BR and PL conditions were compared using a paired Student's t test. T es and T b thresholds and slopes for SR and CVC between BR and PL were compared using two-way repeated-measures ANOVAs (condition × skin region). HR, MAP, T es , T sk , and RPE during exercise were compared using two-way repeated-measures ANOVAs (condition × time) with comparisons of baseline and each 5 min of exercise (baseline, 5, 10, 15, 20, 25, and 30 min) . Three-way repeated measures ANOVAs were performed (condition × time × skin region) for SR and CVC during exercise. A Greenhouse-Geisser correction was applied if the assumption of sphericity was been violated. A Bonferroni correction was applied to control for the multiple comparisons. When an influence of BR supplementation was observed, a linear regression analysis was performed to determine the relationship between V O 2max and the variables (see results). The effect size of each ANOVA was calculated and reported as partial eta-squared values ( 2 p ) and that of each t test was calculated and reported as Cohen's d (d). Data are presented as mean ± SD, and statistical significance was set at P < 0.05. All statistical analyses were performed using a statistical package (SPSS) version 24.0.
Results
Plasma nitrate and nitrite concentrations
Compared with PL, 3 days BR juice supplementation increased resting plasma NO (Table 2) . A supplementation × time interaction effect was observed for MAP (P = 0.035, 2 p = 0.265, 1 − β = 0.782, Fig. 1 ). Post hoc analysis revealed that the BR supplementation lowered MAP during exercise, which attained significance after 30 min of exercise (112 ± 6 and 103 ± 6 mmHg for PL and BR, respectively, P = 0.021, (Fig. 1) .
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Sweating and cutaneous vascular responses
Neither a main effect of supplementation (P = 0.164, 2 p = 0.256, 1 − β = 0.270) nor an interaction effect (all P ≥ 0.121, all 2 p ≤ 0.250, all 1 − β ≤ 0.437) was observed in SR during exercise (Fig. 2) . Similarly, there were no main effects of supplementation (all P ≥ 0.114, all (Table 3) .
Discussion
Contrary to our hypothesis, BR supplementation did not affect local SR and cutaneous vascular responses on the chest or forearm during exercise in hot conditions. On the other hand, we observed a lowered end-exercise blood pressure following BR supplementation during exercise in hot conditions. These results suggest that NO − 3 -rich BR juice supplementation is not likely to influence local sweating and cutaneous vascular responses, but can lower systemic blood pressure during exercise in a hot environment.
Previous studies have reported a fundamental role for NO in the regulation of sweating during exercise, as evidenced by a reduction in SR when NOS activity was inhibited at the skin (Welch et al. 2009; Fujii et al. 2015 Fujii et al. , 2016 . In the present study, plasma NO were significantly increased by BR supplementation (Table 1) , implying an increased potential for O 2 -independent NO production . We reasoned that BR supplementation would increase NO − 2 delivery to sweat glands where cutaneous blood flow was higher, thereby promoting an enhanced sweat response mediated by NO (Welch et al. 2009; Fujii et al. 2015 Fujii et al. , 2016 . We further assumed that NO − 3 and NO − 2 in sweat secreted onto the skin would be reduced to NO, and hence may have diffused through the skin to increase SkBF (Vercelino et al. 2013) . However, the BR-induced increase in plasma NO did not affect local SR on either the forearm or chest (Fig. 2) . In addition, slopes describing the relationship between sweating response on the chest and forearm against the increase in core temperature were not affected by BR supplementation (Table 3) . Therefore, contrary to the previously reported influence of NOSdependent NO production on sweat regulation (Welch et al. 2009; Fujii et al. 2015 Fujii et al. , 2016 ), it appears that augmenting the NO
→ NO pathway does not modify the sweat response during exercise in the heat, at least following shortterm BR administration (3 days) employed herein. Given that NO − 2 -derived NO production is potentiated within hypoxic and acidic tissues , there remains the possibility that exogenous NO − 3 -supplementation may modulate sweating in hot environments at simulated altitude or during high-intensity exercise when NOS-dependent sweating is abolished as well as in exercising older individuals . In addition, given that NOS-dependent sweating is highly variable between individuals (Amano et al. 2017a, b) , it is conceivable that enhancing the NO
→ NO pathway may benefit some (but not all) individuals via an improved sweating response when exercising in the heat. Therefore, further studies are required to elucidate the precise influence of inorganic NO − 3 treatment on sweating during exercise.
It has recently been reported that NO − 3 supplementation increased CVC during passive heating (Levitt et al. 2015) . These authors also reported that the increased CVC was due to a reduction in MAP during normothermic resting and passive hyperthermic conditions, whilst the SkBF per se was not influenced by the supplementation (Levitt et al. 2015) . We did not observe measurable differences in CVC between conditions (Fig. 2 ) despite a reduction in MAP during exercise (Fig. 1) . Given that the CVC was not measurably impacted by BR supplementation in the present study (Fig. 2) , despite a reduction in mean arterial pressure during exercise (Fig. 1 ), it appears that BR supplementation has a distinct influence on cutaneous vascular response between whole body passive heating and exercise. However, the mechanisms for the disparate effects of BR supplementation on cutaneous blood flow during exercise and rest in hyperthermic conditions are unknown and, therefore, warrants further research.
Numerous studies have reported a reduction in blood pressure at rest (Bailey et al. 2009; Keen et al. 2014; Levitt et al. 2015; Larsen et al. 2006; Sobko et al. 2010; Wylie et al. 2013a; Lee et al. 2015) and during exercise (Lee et al. 2015; Bond Jr et al. 2013) following NO − 3 supplementation. Whilst we did not observe a reduction in blood pressure at rest with NO − 3 treatment (Table 2) , this lack of effect has also been reported in some previous studies following NO − 3 supplementation (Cermak et al. 2012; Larsen et al. 2010; Gilchrist et al. 2013 ). In contrast to previous studies that reported an influence of NO − 3 supplementation on blood pressure within thermoneutral ambient conditions, it is noteworthy that we reported a lowering of blood pressure with BR during exercise in a hot environment. On the other hand, a very recent study reported that BR supplementation does not alter blood pressure during exercise in trained cyclists ( V O 2max , 68 ml/ kg/min) in hot conditions (Kent et al. 2018b) . Given that our participants were comparatively less trained ( V O 2max , 43 ml/kg/min) to those assessed in the study by Kent et al. (2018b) , it is possible that aerobic fitness accounted for the inter-study disparity in blood pressure following BR supplementation during exercise in hot conditions. To support this observation, we found that individuals with lower aerobic fitness manifest a larger attenuation of blood pressure during exercise in a hot environment. Notwithstanding this novel observation, given that unstable and falling blood pressure can signal cardiovascular failure during exercise in the heat (Rowell 1974) , our data suggest that ingesting NO − 3 -rich BR prior to exercising in the heat should be implemented with caution, particularly since its effect on exercise performance in a hot environment is currently controversial (Kent et al. 2018a; McQuillan et al. 2018) . While the potential ergogenic effects of BR supplementation appear to be inversely related to aerobic fitness (Porcelli et al. 2015) and is recommended to enhance endurance performance in recreationally active individuals in thermoneutral conditions (Jones 2014) , BR supplement should be used with caution in hot environments to limit the potential for the development of excessive hypotension. It is also interesting that we observed the reduction of MAP at the end of exercise only. It is expected that the lowering blood pressure at the end of exercise might be associated with the fall of blood pH and PO 2 that potentiate the reduction of NO − 2 to NO (Castello et al. 2006; Modin et al. 2001 ) while future investigation is needed to confirm this possibility. Clearly, further studies are required to elucidate the impact and safety of the blood pressure lowering effects of BR supplementation during exercise in hot conditions.
Limitations
There were several limitations in the present study. Firstly, while we observed increases in plasma NO concentrations to verify or refute this possibility. Secondly, given that we did not normalize CVC as % of maximum vasodilation as has previously been conducted Levitt et al. 2015) , the potential inter-day and inter-site variations in cutaneous vascular response might have influenced the reliability of CVC in the present study. Finally, while we tried to conduct female experiments in the same phase of menstrual cycle, there remained a possibility that the circulating sex hormone levels differed between the trials since we did not measure blood sex hormones concentrations in the present study. Given that the sex hormone levels might affect local cutaneous blood flow response through NO dependent mechanism (Charkoudian et al. 1999 ), this point is worthy of future study.
In summary, we showed that 3 days of BR juice supplementation, which increased plasma NO , had no influence on sweating and cutaneous vascular responses at multiple skin sites during exercise in a hot condition among healthy young adults. However, BR juice supplementation lowered mean arterial blood pressure whilst exercising in the heat. Further research is required to assess the risk-reward weighting of this hypotensive effect during exercise in a hot environment.
